Drug – bio-affecting and body treating compositions – Identification or warning feature – Taste or smell or chemical irritation to the eye – nose – or...
Patent
1976-11-08
1979-02-20
Fagelson, Anna P.
Drug, bio-affecting and body treating compositions
Identification or warning feature
Taste or smell or chemical irritation to the eye, nose, or...
23230B, 195 14, 195 63, 195 69, 1951035V, 424 8, 424 86, 424 89, G01N 3100, G01N 3316
Patent
active
041407547
ABSTRACT:
The non-specific inhibitors of hemagglutination in a subject serum for hemagglutination-inhibition test for a togavirus such as rubella virus can be inactivated by subjecting the subject serum to the action of phospholipase C. By subjecting thus-treated serum to the hemagglutination-inhibition test employing fixed erythrocytes the togavirus hemagglutination-inhibition antibody titer of the serum can be determined accurately and with high sensitivity.
REFERENCES:
Nakagawa, Chem. Abs., vol. 52, 1958, p. 20389ghi.
Schmidt, Chem. Abs., vol. 75, 1971, Ab. No. 33041r.
Plotkin, Amer. J. of Epidemiology, vol. 88, Nov. 1968, pp. 301-304.
Gupta, Applied Microbiol., vol. 22, 1971, pp. 921-922.
Haukenes, Med. Microbiol. Immunol., vol. 161, No. 2, 1975, pp. 99-106.
Fagelson Anna P.
Takeda Chemical Industries Ltd.
LandOfFree
Hemagglutination-inhibition test for togaviruses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hemagglutination-inhibition test for togaviruses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hemagglutination-inhibition test for togaviruses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-258599